Esomeprazole: a review of its use in the management of acid-related disorders (Q34716982)

4 August 2017

1 reference

title

Esomeprazole: a review of its use in the management of acid-related disorders (English)

1 reference

4 August 2017

1 reference

1

Lesley J Scott

1 reference

4 August 2017

Christopher J Dunn

2

1 reference

4 August 2017

Gordon Mallarkey

series ordinal

3

1 reference

4 August 2017

Miriam Sharpe

series ordinal

4

1 reference

4 August 2017

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

62

1 reference

4 August 2017

10

1 reference

4 August 2017

1503-1538

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262100-00006

4 August 2017

0 references

cites work

Increasing concerns about chronic proton pump inhibitor use.

1 reference

12 December 2020

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease

1 reference

12 December 2020

1 reference

12 December 2020

Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease

1 reference

12 December 2020

The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease.

1 reference

12 December 2020

Pharmacological therapy of Helicobacter pylori infection

1 reference

12 December 2020

Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines.

1 reference

12 December 2020

Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?

1 reference

12 December 2020

Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life

1 reference

12 December 2020

Evidence for therapeutic equivalence of lansoprazole 30mg and esomeprazole 40mg in the treatment of erosive oesophagitis

1 reference

12 December 2020

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

1 reference

12 December 2020

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

1 reference

12 December 2020

Management of severe gastroesophageal reflux disease

1 reference

12 December 2020

Nonerosive reflux disease--current concepts and dilemmas

1 reference

12 December 2020

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

12 December 2020

Rabeprazole: an update of its use in acid-related disorders

1 reference

12 December 2020

Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.

1 reference

12 December 2020

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

1 reference

12 December 2020

One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease

1 reference

12 December 2020

Treatment of Helicobacter pylori

1 reference

12 December 2020

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study

1 reference

12 December 2020

Formulary management of proton pump inhibitors

1 reference

12 December 2020

Bile reflux and oesophagitis

1 reference

12 December 2020

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Recognizing atypical manifestations of GERD. Asthma, chest pain, and otolaryngologic disorders may be due to reflux

1 reference

12 December 2020

Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies

1 reference

12 December 2020

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

12 December 2020

Lansoprazole: an update of its place in the management of acid-related disorders

1 reference

12 December 2020

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

1 reference

12 December 2020

Clinical economics review: gastrointestinal disease in primary care

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with impaired renal function

1 reference

12 December 2020

What do we know about gastroesophageal reflux disease?

1 reference

12 December 2020

The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety

1 reference

12 December 2020

Long-term management of gastroesophageal reflux disease and its complications

1 reference

12 December 2020

Acid stimulates E-cadherin surface expression on gastric epithelial cells to stabilize barrier functions via influx of calcium

1 reference

12 December 2020

The epidemiology of gastroesophageal reflux disease: what we know and what we need to know

1 reference

12 December 2020

Gastroesophageal reflux disease

1 reference

12 December 2020

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

12 December 2020

Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders

1 reference

12 December 2020

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization

1 reference

12 December 2020

Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers

1 reference

12 December 2020

Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Treatment of gastro-oesophageal reflux disease in adults

1 reference

12 December 2020

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

1 reference

12 December 2020

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.

1 reference

12 December 2020

Gastroduodenal ulcers: causes, diagnosis, prevention and treatment

1 reference

12 December 2020

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

12 December 2020

Debating the role of Helicobacter pylori infection.

1 reference

12 December 2020

Rabeprazole: a review of its use in acid-related gastrointestinal disorders

1 reference

12 December 2020

Pharmacokinetic study of esomeprazole in the elderly

1 reference

12 December 2020

Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.

1 reference

12 December 2020

Proton-pump inhibitors in acid-related diseases.

1 reference

12 December 2020

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

12 December 2020

Management of gastro-oesophageal reflux disease in general practice

1 reference

12 December 2020

Treatment of Helicobacter pylori

1 reference

12 December 2020

Importance of pH control in the management of GERD.

1 reference

12 December 2020

Peptic ulcer disease and current approaches to Helicobacter pylori

1 reference

12 December 2020

Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).

1 reference

12 December 2020

Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

1 reference

12 December 2020

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

12 December 2020

Esomeprazole (nexium)

1 reference

12 December 2020

Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis

1 reference

12 December 2020

Pharmacokinetic study of esomeprazole in patients with hepatic impairment

1 reference

12 December 2020

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

12 December 2020

Quality of life and cost of therapy in reflux disease.

1 reference

12 December 2020

The proton-pump inhibitors: similarities and differences

1 reference

12 December 2020

Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

12 December 2020

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

1 reference

12 December 2020

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy

1 reference

12 December 2020

Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED)

1 reference

12 December 2020

Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia

1 reference

12 December 2020

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

1 reference

12 December 2020

Strategies for medical management of reflux disease

1 reference

12 December 2020

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

1 reference

12 December 2020

10.2165/00003495-200262100-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference